• Problem
  • Solution
  • Technology
  • News
  • Team
Resistell News

Thank you for giving us the opportunity to take part in the Pitch Night Boston 2019: The Future of HealthTech and to present our rapid AST.

Read more
 
Join Resistell at OBERON to see our Rapid AST solution at Pitch Night 2019, where 10 of Switzerland’s most promising young HealthTech startups will pitch their ideas alongside their counterparts from North America, including some of the Boston area’s favorite early Life Sciences startups.
Read more
image source: Wikipedia
 
We would like to thank the colleagues from the Uppsala Antibiotic Centre for the invitation to an excellent Symposium on Rapid ASTs. We are impressed by the quality of the event, participants and the discussions and honoured to be an invited speaker.
Read more
 
Learn more on rapid phenotypic antibiotic susceptibility test and Danuta's expectations on her roadshow in Boston.
Read more
 
a thrilling evening for innovators in Switzerland
Read more
image source: venturelab.ch
 
Danuta selected as top four up-and-coming entrepreneurs who made the best pitch at the annual Startup Champions Seed Night. Watch us on CNN Money and see how we will take our startup to the next level.
Read more
 
We invite you to meet us in Amsterdam at ECCMID 2019 (13 - 16 April 2019) and learn more about our rapid AST approach, see the product and discuss the future cooperations. Meet us any time at the booth 1.107!
Read more
image source: ECCMID
 
D.Day 2019 – Discover what your neighbours are working on!
Read more
 
“This process is one of the most rapid methods in this review and can be used to develop quantitative anti-biograms”, Puttaswamy et al., 2018, Archives of Clinical Microbiology, 9:3, 83 https://doi.org/10.4172/1989-8436.100083
Read more
 
Well done to all our colleagues from CHUV Hospital, recently listed in the top 10 best hospitals in the world. Resistell is proud to develop the rapid AST with the support of CHUV Hospital. Thank you and congratulations!
Read more
image source: Newsweek
 
Resistell was selected as one of ten new startups have been selected for Venture Leaders Life Sciences 2019. Chosen from among the most-promising life sciences startups in Switzerland, the team will embark on a packed, week-long roadshow in Boston. The startups will also pitch at the Startup Champions Seed Night event in Lausanne on 11 April.
Read more
image source: startupticker.ch
 
"Enough time has been wasted issuing warnings about antibiotic resistance. The moment has come to do something about it” The Economist
Read more
image source: The Economist
 
Bilan selected Resistell as one of the Top 50 Swiss startups in which to invest in 2019! We are proud to be on the prestigious list with our rapid AST technology!
Read more
image source: bilan.ch
 
We thank everyone who visited our scientific presentation in Berlin at Novel Antimicrobials & AMR Diagnostics Conference (14-15.03.2019). We are looking forward to all new future partnerships and collaborations!
Read more
 
We invite you to meet us in Berlin at Novel Antimicrobials & AMR Diagnostics Conference (14-15.03.2019). For more details please visit https://amr-conference.com
Read more
 
The jury of industry experts and investors selected Resistell to receive the highest level of Venture Kick’s financial support to bring their businesses to market.
Read more
 
Resistell has closed an oversubscribed seed financing round. Lead Investor Occident Group AG, Hemex AG and six other private investors invested in the EPFL spin-off developing the world’s fastest phenotypic antibiotic susceptibility test.
Read more
image source: startupticker.ch
 
Resistell AG a finalist of the Swiss Technology Award 2018!
Read more
image source: startupticker.ch
 
Resistell wins the MassChallenge Switzerland 2018 Gold Award
Read more
 
Join us at the annual meeting of the Swiss Society for Microbiology held within the CHUV, Lausanne.
Read more
image source: Lausanne Tourisme
 
We are please to share that on 07.06.2018 in Zurich, Resistell has received the Swiss Nanotechnology Startup Award for the Best Nanotechnology Startup 2018.
Read more
 
Last week, we competed with over 200 startups from 31 countries in final judging round at Campus Biotech in Geneva. We are pleased to inform that Resistell AG qualified to the finals!
Read more
 
31.05.2018 - Resistell's team has won the Venture Kick stage 2!
Read more
 
SNSF NRP 72 Antimicrobial Resistance about Resistell.
Read more
 
On 02.03.2018 the Resistell team presented at Novel Antimicrobials and AMR Diagnostics conference in Berlin. Our MVP attracted a lot of attention!
Read more
 
We invite you to meet us in Berlin at Novel Antimicrobials & AMR Diagnostics Conference (02.03.2018). We welcome you at our stand and invite to see our pitch.
Read more
 
Four new startups get CHF 10,000
Read more
 
Three questions for Danuta Cichocka (EMBA’16), founder of Resistell
Read more
 
We are pleased to announce our new location in BASEL INKUBATOR, Hochbergerstr. 60c, CH 4057 Basel
Read more
 
Resistell qualified to take part in a pitching battle at Swiss Startup Days 2017
Read more
 
A successful event with Solothurn
Read more
 
Im Rahmen des ersten Swiss Diagnostics Start-Up Day 2017 an der Fachhochschule Nordwestschweiz präsentierten sechs Start-Ups aus der Biotechnologie und Diagnostik ihre Geschäftsideen einer Expertenjury.
Read more
 
Congratulations to the Winner of the first Swissbiolabs Challenge, Danuta Cichocka for her great presentation and innovative idea!
Read more
Stories by